Aptamer Group PLC (APTA) - Total Liabilities
Based on the latest financial reports, Aptamer Group PLC (APTA) has total liabilities worth GBX1.45 Million GBX (≈ $176.67 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Aptamer Group PLC - Total Liabilities Trend (2019–2025)
This chart illustrates how Aptamer Group PLC's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Aptamer Group PLC to evaluate short-term liquidity relative to the company's equity base.
Aptamer Group PLC Competitors by Total Liabilities
The table below lists competitors of Aptamer Group PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ImagineAR Inc
F:GMS1
|
Germany | €3.53 Million |
|
Captivision Inc
NASDAQ:CAPT
|
USA | $80.62 Million |
|
Fusion Antibodies PLC
LSE:FAB
|
UK | GBX1.09 Million |
|
Northern Bear Plc
LSE:NTBR
|
UK | GBX22.35 Million |
|
Haydale Graphene Industries
LSE:HAYD
|
UK | GBX6.69 Million |
|
Tekcapital plc
LSE:TEK
|
UK | GBX497.60K |
|
Conygar Investment Co PLC
LSE:CIC
|
UK | GBX59.48 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Aptamer Group PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Aptamer Group PLC worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aptamer Group PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aptamer Group PLC (2019–2025)
The table below shows the annual total liabilities of Aptamer Group PLC from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | GBX1.45 Million ≈ $176.67 |
-22.85% |
| 2024-06-30 | GBX1.88 Million ≈ $228.98 |
-23.15% |
| 2023-06-30 | GBX2.45 Million ≈ $297.97 |
-29.40% |
| 2022-06-30 | GBX3.47 Million ≈ $422.08 |
+77.08% |
| 2021-06-30 | GBX1.96 Million ≈ $238.35 |
+71.25% |
| 2020-03-31 | GBX1.14 Million ≈ $139.19 |
+130.06% |
| 2019-03-31 | GBX497.25K ≈ $60.50 |
-- |
About Aptamer Group PLC
Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and … Read more